Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Digital Health Trends 2024 - Implications for Research and Patient Care

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • IQVIA AI Assistant
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience Solutions with Apple devices
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE
Meet the IQVIA AI Assistant

Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.

LEARN MORE
Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions with Apple devices

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/
White Paper
Pharmacy Compliance Report
Analysis of Potential Pharmacy Fines & Savings
May 10, 2018
  • Library
  • Pharmacy Compliance Report
To download files, please accept Functional Cookies. These cookies provide enhanced functionality for a better user experience.

Federal efforts to curb prescription drug abuse and deaths have put pharmacies under tremendous pressure to verify prescriber credentials for hydrocodone combination products (HCPs), such as Vicodin, Lorcet and Lortab. Using data from OneKey Pharmacy Central Prescriber Validation, this report details the number of problematic DEA numbers, NPI numbers, OIG exclusions and inactive prescriber credentials that pharmacy customers saw from June to December 2016.

The reschedule of hydrocodone combination products (HCP) in 2014 has had critical logistical implications for U.S. pharmacies. Prior to the reschedule, many pharmacies were not in the regular practice of validating prescriber DEA credentials. In fact, a 2005 CASAColumbia study found that only 70 percent of pharmacists did so on a regular basis.

Under today’s environment of enforcement, however, pharmacies that fail to comply with regulatory requirements face serious consequences.

Changes in HCP prescription drug policies have been unfolding since 2004, when the U.S. Drug Enforcement Agency (DEA) first attempted to tighten restrictions. In 2013, recommendations by the Food and Drug Administration’s Drug Safety and Risk Management Advisory Committee (DSaRM) led to the 2014 reschedule. Since then, federal agencies and even Congress have given serious attention to the prevention of prescription opioid abuse and deaths, the latter of which reached historic numbers (more than 165,000) in 2014 .

Despite its decision in 2008 to keep HCPs classified as schedule III drugs, the U.S. Department of Health and Human Services (HHS) has now declared opioid prescription abuse and death a public health epidemic. Pharmacies are now being called on to be partners in the effort to combat opioid prescription drug abuse and deaths. To do so, pharmacies must ensure that their validation systems and processes are equipped to access the most up-to-date prescriber DEA data available.

With U.S. pharmacies filling more than 4 billion prescriptions every year, the ability to verify and validate prescriber credentials in a timely, efficient and accurate manner is not only vital for compliance but also for business.

As this pharmacy compliance report shows, pharmacies that fail to comply with the federal regulations governing Schedule II are subject to fines amounting to billions of dollars in just a six-month period. Additionally, failure to validate other data, including NPI numbers and OIG exclusions, can result in rejected reimbursements and withdrawals of payment.

The OneKey Central Prescriber Validation (CPV) solution provides modern pharmacies with a powerful, cost-effective and streamlined validation service to support current and future regulatory demands. The integration of OneKey CPV with QuintilesIMS, the largest healthcare data provider in the industry, has added a level of breadth that is unmatched in its capabilities and strength.


DOWNLOAD TO LEARN MORE
Contact Us